{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:22:54Z","timestamp":1794565374813,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2102300"],"award-info":[{"award-number":["2021YFC2102300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22375144"],"award-info":[{"award-number":["22375144"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071384"],"award-info":[{"award-number":["32071384"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["262300422158"],"award-info":[{"award-number":["262300422158"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biomaterials.2026.124272","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:00:01Z","timestamp":1778108401000},"page":"124272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Engineered metallo-albumin nanoscaffolds that target lymph nodes, deliver antigens and activate STING for cancer immunotherapy"],"prefix":"10.1016","volume":"334","author":[{"given":"Boyang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuzhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan F.","family":"Lovell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6166-0470","authenticated-orcid":false,"given":"Yumiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124272_bib1","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2026.124272_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124272_bib3","doi-asserted-by":"crossref","first-page":"11109","DOI":"10.1021\/acs.chemrev.5b00109","article-title":"Synthetic nanoparticles for vaccines and immunotherapy","volume":"115","author":"Irvine","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124272_bib4","article-title":"Harnessing nanomaterials to precisely regulate the immunosuppressive tumor microenvironment for enhanced immunotherapy","author":"Zhang","year":"2025","journal-title":"BMEMat n\/a"},{"key":"10.1016\/j.biomaterials.2026.124272_bib5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/bmm2.12112","article-title":"Nano\/genetically engineered cells for immunotherapy","volume":"3","author":"Shen","year":"2025","journal-title":"BMEMat"},{"key":"10.1016\/j.biomaterials.2026.124272_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","article-title":"Designing spatial and temporal control of vaccine responses","volume":"7","author":"Roth","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.biomaterials.2026.124272_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol.J Hematol Oncol"},{"key":"10.1016\/j.biomaterials.2026.124272_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2022.09.015","article-title":"Lymph node-targeting nanovaccines for cancer immunotherapy","volume":"351","author":"Wang","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124272_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113914","article-title":"Vaccine delivery systems toward lymph nodes","volume":"179","author":"Ding","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124272_bib11","doi-asserted-by":"crossref","unstructured":"M. Liu, Y. Feng, Y. Lu, R. Huang, Y. Zhang, Y. Zhao, R. Mo, Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy, Sci. Adv. 10 (n.d.) eadk2444.","DOI":"10.1126\/sciadv.adk2444"},{"key":"10.1016\/j.biomaterials.2026.124272_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2019.06.002","article-title":"Formulation and manufacturing of lymphatic targeting liposomes using microfluidics","volume":"307","author":"Khadke","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124272_bib13","article-title":"Cell-based delivery systems: emerging carriers for immunotherapy","volume":"31","author":"Li","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2026.124272_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41565-020-0679-4","article-title":"Programmable multistage drug delivery to lymph nodes","volume":"15","author":"Schudel","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib15","doi-asserted-by":"crossref","first-page":"13809","DOI":"10.1021\/acsnano.9b04071","article-title":"Exploiting the lymph-node-amplifying effect for potent systemic and gastrointestinal immune responses via polymer\/lipid nanoparticles","volume":"13","author":"Du","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124272_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006007","article-title":"Development of a cancer vaccine using in vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124272_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202100106","article-title":"Engineering the deformability of albumin-stabilized emulsions for lymph-node vaccine delivery","volume":"33","author":"Song","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124272_bib18","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124272_bib19","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1007\/s12274-018-2171-0","article-title":"Current taxane formulations and emerging cabazitaxel delivery systems","volume":"11","author":"Sun","year":"2018","journal-title":"Nano Res."},{"key":"10.1016\/j.biomaterials.2026.124272_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1854","article-title":"Current development of cabazitaxel drug delivery systems","volume":"15","author":"Sun","year":"2023","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib21","first-page":"171","article-title":"Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles","volume":"132","author":"Kratz","year":"2008","journal-title":"Proc. Tenth Eur. Symp. Control. Drug Deliv."},{"key":"10.1016\/j.biomaterials.2026.124272_bib22","first-page":"331","article-title":"A clinical update of using albumin as a drug vehicle \u2014 a commentary","volume":"190","author":"Kratz","year":"2014","journal-title":"30th Anniv. Spec. Issue"},{"key":"10.1016\/j.biomaterials.2026.124272_bib23","doi-asserted-by":"crossref","unstructured":"J. Wang, S. Li, M. Wang, X. Wang, S. Chen, Z. Sun, X. Ren, G. Huang, B.D. Sumer, N. Yan, Y.-X. Fu, J. Gao, STING licensing of type I dendritic cells potentiates antitumor immunity, Sci. Immunol. 9 (n.d.) eadj3945.","DOI":"10.1126\/sciimmunol.adj3945"},{"key":"10.1016\/j.biomaterials.2026.124272_bib24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41576-019-0151-1","article-title":"DNA sensing by the cGAS\u2013STING pathway in health and disease","volume":"20","author":"Motwani","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biomaterials.2026.124272_bib26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41422-020-00395-4","article-title":"Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy","volume":"30","author":"Lv","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2026.124272_bib27","article-title":"Metal coordination-driven assembly of stimulator of interferon genes-activating nanoparticles for tumor chemo-immunotherapy","volume":"2","author":"Zhang","year":"2024","journal-title":"BMEMat"},{"key":"10.1016\/j.biomaterials.2026.124272_bib28","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.4049\/jimmunol.1100088","article-title":"MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers Cyclic-di-AMP and Cyclic-di-GMP","volume":"187","author":"Jin","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.abb4255","article-title":"Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic","volume":"369","author":"Chin","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124272_bib30","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124272_bib31","doi-asserted-by":"crossref","first-page":"16909","DOI":"10.1021\/acsnano.2c06926","article-title":"Manganese coordination micelles that activate stimulator of interferon genes and capture in situ tumor antigens for cancer metalloimmunotherapy","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124272_bib32","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1038\/s41467-018-06922-7","article-title":"Structural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1","volume":"9","author":"Kato","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124272_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114943","article-title":"Structure-activity relationship study of amidobenzimidazole derivatives as stimulator of interferon genes (STING) agonists","volume":"246","author":"Liu","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124272_bib34","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2032-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24224192","article-title":"ENPP1, an old enzyme with new functions, and small molecule inhibitors\u2014A STING in the tale of ENPP1","volume":"24","author":"Onyedibe","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2026.124272_bib36","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41565-020-00782-3","article-title":"Proton-driven transformable nanovaccine for cancer immunotherapy","volume":"15","author":"Gong","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib37","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","article-title":"A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy","volume":"15","author":"Xu","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12057","article-title":"Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery","volume":"10","author":"Pham","year":"2021","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.biomaterials.2026.124272_bib39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/bc200065z","article-title":"The controlled display of biomolecules on nanoparticles: a challenge suited to bioorthogonal chemistry","volume":"22","author":"Algar","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biomaterials.2026.124272_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2020.01.035","article-title":"Functionalizing nanoparticles with cancer-targeting antibodies: a comparison of strategies","volume":"320","author":"Marques","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124272_bib41","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41565-018-0271-3","article-title":"A malaria vaccine adjuvant based on recombinant antigen binding to liposomes","volume":"13","author":"Huang","year":"2018","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib42","article-title":"SARS-CoV-2 RBD neutralizing antibody induction is enhanced by particulate vaccination","volume":"32","author":"Huang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124272_bib43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nri1632","article-title":"NFAT proteins: key regulators of T-cell development and function","volume":"5","author":"Macian","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib44","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11699","article-title":"Ca2+ regulates T-cell receptor activation by modulating the charge property of lipids","volume":"493","author":"Shi","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124272_bib45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrmicro2836","article-title":"Nutritional immunity: transition metals at the pathogen\u2013host interface","volume":"10","author":"Hood","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.biomaterials.2026.124272_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","article-title":"Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses","volume":"48","author":"Wang","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124272_bib47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1126\/science.aat1022","article-title":"DNA-induced liquid phase condensation of cGAS activates innate immune signaling","volume":"361","author":"Du","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124272_bib48","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41929-019-0305-8","article-title":"Highly active enzyme\u2013metal nanohybrids synthesized in protein\u2013polymer conjugates","volume":"2","author":"Li","year":"2019","journal-title":"Nat. Catal."},{"key":"10.1016\/j.biomaterials.2026.124272_bib49","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.nantod.2024.102156","article-title":"A metalloprotein nanoparticle scaffold co-delivers antigens and adjuvants with metal-enhanced STING activation for vaccination preventing viral infections","volume":"55","author":"Li","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124272_bib50","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1021\/acsnano.0c07680","article-title":"A potent cancer vaccine adjuvant system for particleization of short, synthetic CD8+ T cell epitopes","volume":"15","author":"He","year":"2021","journal-title":"ACS Nano"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:21:05Z","timestamp":1794561665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S0142961226002966"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124272","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineered metallo-albumin nanoscaffolds that target lymph nodes, deliver antigens and activate STING for cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124272"}}